Cardinal Health (NYSE:CAH) Vs Danaher Corporation (NYSE:DHR) – Here’s The One Jim Cramer Said Did Better The recent stock performance of Cardinal Health has been a topic of interest among market analysts and investors.
In September, Jim Cramer publicly questioned whether the company's share price weakness was due to a rotation into AI stocks or a genuine decline in performance.
At first glance, it appears that Cardinal Health's fiscal fourth quarter earnings report, which beat analyst estimates on profit per share, should have been enough to reassure investors.